01 12Care4 Aps
02 1AUROBINDO PHARMA ITALIA Srl
03 1Abacus Medicine A/S
04 1Accord Healthcare Ireland Ltd
05 2Accord Healthcare Slu
06 1Aurobindo Pharma (Malta) Limited
07 1Aurovitas Spain, Sau
08 5BOEHRINGER INGELHEIM INT.GMBH
09 2Boehringer Ingelheim (Switzerland) Gmbh
10 3Boehringer Ingelheim Int. Gmbh
11 3Boehringer Ingelheim International GmbH
12 14Boehringer Ingelheim International Gmbh
13 3Ebb Medical Ab
14 1Kern Pharma Sl
15 1Macleods Pharmaceuticals Limited
16 2Medical Valley Invest Ab
17 1Mepha Pharma Ag
18 1Mylan Ab
19 1Mylan Pharmaceuticals Sl
20 1Normon Laboratories Sa
21 1Orifarm Ab
22 1Paranova Pharmaceuticals Ab
23 1SANDOZ GMBH
24 1Sandoz A/S
25 1Sandoz Pharmaceuticals Ag
26 1Sandoz Pharmaceuticals Sa
27 1Sandoz Pharmaceuticals d.d.
28 1TEVA B.V.
29 1Tarbis Farma Sl
30 4Teva Bv
31 1Teva Pharma Slu
32 1Viatris Limited
33 1Viatris Pharma Gmbh
01 44Nevirapine
02 16Nevirapine (Anhydrous)
03 1Nevirapine Anhydrous
04 1Nevirapine, Anhydrous
01 6Extended-Release Tablet
02 2Modified Release Tablet
03 1Nevirapine 100Mg 90 Combined Oral Use Rp
04 1Nevirapine 200Mg 14 Joined' Oral Use
05 4Nevirapine 200Mg 60 Units Oral Use
06 1Nevirapine 400Mg 30 Joined' Oral Use Rp
07 1Nevirapine 50Mg/5Ml 240Ml Oral Use
08 4Oral Suspension
09 2Prolonged Release Tablet
10 5Prolonged-Release Tablet
11 34Tablet
12 1UNCOATED TABLET
01 6Denmark
02 4Estonia
03 8Italy
04 3Malta
05 4Norway
06 15Spain
07 16Sweden
08 5Switzerland
09 1United Kingdom
01 2Nevirapina Accord
02 1Nevirapina Kern Pharma
03 1Nevirapina Mylan
04 1Nevirapina Normon
05 1Nevirapina Sandoz
06 2Nevirapina Teva
07 4Nevirapine
08 1Nevirapine 2Care4
09 1Nevirapine Accord
10 1Nevirapine Aurobindo
11 1Nevirapine Aurovitas
12 2Nevirapine Ebb
13 2Nevirapine Medical Valley
14 1Nevirapine Mylan
15 1Nevirapine Orifarm
16 1Nevirapine Paranova
17 1Nevirapine Sandoz
18 1Nevirapine Sandoz Retard
19 1Nevirapine Tarbis Pharma
20 1Nevirapine Teva
21 1Nevirapine Teva Bv
22 1Nevirapine Viatris
23 1Nevirapine "Medical Valley"
24 1Nevirapine "Teva B.V."
25 1Nevirapine "Viatris"
26 1Nevirapine-Mepha
27 28Viramune
28 1Blank
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Nevirapine 2Care4
Dosage Form : Tablet
Dosage Strength : 400mg
Packaging :
Approval Date : 07-09-2021
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Viramune
Dosage Form : Tablet
Dosage Strength : 400mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Withdrawn
Registration Country : Malta
Brand Name : Nevirapine Accord
Dosage Form : Prolonged-Release Tablet
Dosage Strength : 400MG
Packaging :
Approval Date : 2017-03-27
Application Number :
Regulatory Info : Withdrawn
Registration Country : Malta
Regulatory Info : Cancelled
Registration Country : Spain
Brand Name : Nevirapina Accord
Dosage Form : Extended-Release Tablet
Dosage Strength : 400MG
Packaging :
Approval Date : 24-06-2017
Application Number : 82180
Regulatory Info : Cancelled
Registration Country : Spain
Regulatory Info : Cancelled
Registration Country : Spain
Brand Name : Nevirapina Accord
Dosage Form : Tablet
Dosage Strength : 200MG
Packaging :
Approval Date : 16-04-2012
Application Number : 75787
Regulatory Info : Cancelled
Registration Country : Spain
Regulatory Info :
Registration Country : Italy
Brand Name : Nevirapine
Dosage Form : Nevirapine 200Mg 60 Units Oral Use
Dosage Strength : 60 CPR 200 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : Withdrawn
Registration Country : Malta
Brand Name : Nevirapine Aurobindo
Dosage Form : Tablet
Dosage Strength : 200MG
Packaging :
Approval Date : 2013-05-03
Application Number :
Regulatory Info : Withdrawn
Registration Country : Malta
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Viramune
Dosage Form : Tablet
Dosage Strength : 200mg
Packaging :
Approval Date : 23/12/1997
Application Number : 54393
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Viramune
Dosage Form : Prolonged Release Tablet
Dosage Strength : 400mg
Packaging :
Approval Date : 10/01/2012
Application Number : 62077
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Suspended
Registration Country : Spain
Brand Name : Nevirapine Aurovitas
Dosage Form : Extended-Release Tablet
Dosage Strength : 400MG
Packaging :
Approval Date : 08-04-2021
Application Number : 85896
Regulatory Info : Suspended
Registration Country : Spain
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
